Functional annotation of genomic variation: DNA methylation episignatures in neurodevelopmental Mendelian disorders. (9th July 2020)

• Record Type: Journal Article
• Authors: Sadikovic, Bekim; Levy, Michael A; Aref-Eshghi, Erfan
• Is Part Of: Human molecular genetics. Volume 29:Number R1(2020)
• Page Start: R27
• Page End: R32
• Publication Date: 2020-07-09
• Subjects: Human molecular genetics -- Periodicals; Human chromosome abnormalities -- Periodicals; 572.8
• DOI: 10.1093/hmg/ddaa144
• Languages: English
• ISSNs: 0964-6906

Abstract

Abstract: The breadth and complexity of genetic testing in patients with suspected Mendelian neurodevelopmental disorders has rapidly expanded in the past two decades. However, in spite of advances in genomic technologies, genetic diagnosis remains elusive in more than half of these patients. Epigenomics, and in particular genomic DNA methylation profiles, are now known to be associated with the underpinning genetic defects in a growing number of Mendelian disorders. These often highly specific and sensitive molecular biomarkers have been used to screen these patient populations, resolve ambiguous clinical cases and interpret genetic variants of unknown clinical significance. Increasing the diagnostic yield beyond genomic sequencing technologies has rapidly propelled epigenomics to clinical utilization, with recent introduction of DNA methylation 'EpiSign' analysis in clinical diagnostic laboratories. This review provides an overview of the principles, applications and limitations of DNA methylation episignature analysis in patients with neurodevelopmental Mendelian disorders, and discusses clinical implications of this emerging diagnostic technology.